MedCity News January 28, 2025
Quibim’s technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startup’s customers, using its technology to analyze images to detect disease and guide clinical trial enrollment.
As the saying goes, a picture is worth 1,000 words. But when it comes to medical imaging, sometimes those pictures just don’t say enough. Startup Quibim uses artificial intelligence to glean more insights from medical images and it has raised $50 million to continue commercializing its technology and to ramp up R&D that could broaden its offerings.
“The main goal for the company is we would like to lead the category of imaging-based personalized medicine,” founder and CEO Ángel Alberich-Bayarri said.
The Quibim technology stems...
Today's Sponsors
Today's Sponsor